首页> 外文OA文献 >Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro
【2h】

Ethanol Extract from Ampelopsis sinica Root Exerts Anti-Hepatitis B Virus Activity via Inhibition of p53 Pathway In Vitro

机译:中华根的乙醇提取物通过抑制p53途径体外发挥抗乙型肝炎病毒活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ampelopsis sinica root is widely used in Chinese folk medicine for treating liver disorders caused by the hepatitis B virus (HBV). The present study was performed in order to investigate the anti-HBV activity and mechanisms of the ethanol extract from A. sinica root (EASR) in vitro. The antiviral activity of EASR was examined by detecting the levels of HBsAg, HBeAg and extracellular HBV DNAs in stable HBV-producing human hepatoblastoma HepG2 2.2.15 cells. We found that EASR effectively suppressed the secretion of HBsAg and HBeAg from HepG2 2.2.15 cells in a dose-dependent manner, and it also suppressed the amount of extracellular HBV DNA. After EASR treatment, the percentage of apoptotic cells was found to be significantly higher than that of control by flow cytometric analysis. A luciferase reporter gene assay was used to determine the effects of EASR on the activities of HBV promoters and intracellular signaling pathways. The results showed that EASR selectively inhibited the activities of HBV promoters (Cp, S1p and Fp) and the p53 signaling pathway in HepG2 cells significantly. These data indicate that EASR exerts anti-HBV effects via inhibition of HBV promoters and the p53-associated signaling pathway, which helps to elucidate the mechanism underlying the potential therapeutic value of EASR.
机译:中华根菜被广泛用于治疗由乙型肝炎病毒(HBV)引起的肝脏疾病。进行本研究是为了研究中华曲霉(EASR)乙醇提取物的体外抗HBV活性及其机制。通过检测稳定的产生HBV的人肝母细胞瘤HepG2 2.2.15细胞中HBsAg,HBeAg和细胞外HBV DNA的水平来检查EASR的抗病毒活性。我们发现,EASR以剂量依赖性方式有效抑制了HepG2 2.2.15细胞中HBsAg和HBeAg的分泌,并且还抑制了细胞外HBV DNA的量。通过流式细胞仪分析,EASR处理后,凋亡细胞的百分比显着高于对照细胞。荧光素酶报告基因测定用于确定EASR对HBV启动子活性和细胞内信号通路的影响。结果表明,EASR选择性抑制HepG2细胞中HBV启动子的活性(Cp,S1p和Fp)和p53信号通路。这些数据表明,EASR通过抑制HBV启动子和与p53相关的信号通路发挥抗HBV作用,这有助于阐明潜在的EASR治疗价值的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号